My Health News » Medical News Today - Cancer/Oncology News

Feeds

309896 items (309896 unread) in 46 feeds

World Health Organization (748 unread)

• WHO news (360 unread)
• Disease Outbreak News (388 unread)

Media (241624 unread)

• Reuters Health eLine (10068 unread)
• CNN Health (3619 unread)
• NPR Health and Science (4849 unread)
• ABC News: Health (7706 unread)
• CBSnews.com: Health News (8160 unread)
• BBC Health News (7296 unread)
• CBC Health and Science News (6853 unread)
• Australia ABC News: Health (14541 unread)
• China Xinghua Health News (8874 unread)
• New York Times: Health (13172 unread)
• USATODAY.com Health - Top Stories (5515 unread)
• The Seattle Times: Health (5298 unread)
• International Herald Tribune: Health and Science (4811 unread)
• HeraldToday.com: Health (2842 unread)
• WebMD Health Headlines (6577 unread)
• MedicineNet Daily News (13733 unread)
• Medical News Today (75858 unread)
• iVillage Health (956 unread)
• Topix.net - Health (5904 unread)
• Newsvine - health (34992 unread)

Bird Flu (5364 unread)

• MSNBC.com: Bird Flu (171 unread)
• Topix.net - Bird Flu (3233 unread)
• Medical News Today - Bird Flu/Avian Flu (739 unread)
• MedicineNet Cold and Flu General (1221 unread)

Diabetes (11083 unread)

• Topix.net - Diabetes (5649 unread)
• Medical News Today - Diabetes (3952 unread)
• MedicineNet Diabetes General (1482 unread)

Cholesterol (4292 unread)

• Topix.net - Cholesterol (1763 unread)
• Medical News Today - Cholesterol (627 unread)
• MedicineNet Cholesterol General (1902 unread)

Cancer (22988 unread)

• MSNBC.com: Cancer (882 unread)
• Topix.net - Cancer (5469 unread)
• Medical News Today - Breast Cancer News (3064 unread)
• Medical News Today - Cancer/Oncology News (10502 unread)
• MedicineNet Cancer General (3071 unread)

HIV (12615 unread)

• Topix.net - HIV/AIDS (5026 unread)
• Medical News Today - HIV/AIDS News (7134 unread)
• MedicineNet HIV General (455 unread)

Women (8653 unread)

• MSNBC.com: Women's Health (552 unread)
• Medical News Today - OBGYN News (5685 unread)
• MedicineNet Womens Health General (2416 unread)

Men (2529 unread)

• MSNBC.com: Men's Health (249 unread)
• Medical News Today - Men's health News (1071 unread)
• MedicineNet Mens Health General (1209 unread)

Medical News Today - Cancer/Oncology News (30 unread)

• 2010 Recipient Of Minority Scholar Award Will Conduct Clinical Research On Leukemia

  Posted: March 10th, 2010, 10:00am CST

  Alison Walker, MD, has been selected to receive the ASH-AMFDP Award, and will begin her research in acute myeloid leukemia in July of this year...

• Research Identifies New Mechanism Regulating Embryonic Development

  Posted: March 10th, 2010, 7:00am CST

  A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer...

• Genetic Variant Greatly Increases Lung Cancer Risk For Light Smokers

  Posted: March 10th, 2010, 6:00am CST

  Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati (UC) has concluded...

• Cellectar Completes Enrollment In Phase I Clinical Trial Of Lead Drug Candidate (131)I-CLR1404 For The Treatment Of Solid Malignancies

  Posted: March 10th, 2010, 4:00am CST

  Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year...

• University Of Florida Researchers Find Cancer-fighting Properties In Papaya Tea

  Posted: March 10th, 2010, 4:00am CST

  The humble papaya is gaining credibility in Western medicine for anticancer powers that folk cultures have recognized for generations. University of Florida researcher Nam Dang, M.D., Ph.D., and colleagues in Japan have documented papaya's dramatic anticancer effect against a broad range of lab-grown tumors, including cancers of the cervix, breast, liver, lung and pancreas...

• Professor Discovers Link Between Low Oxygen Levels In Body And Cancer-Aiding Protein; Could Help Treatments For Retinoblastoma, Breast Cancer

  Posted: March 10th, 2010, 3:00am CST

  What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma...

• Dependence Receptors : A New Weapon To Inhibit Tumors?

  Posted: March 10th, 2010, 3:00am CST

  The interaction of a ligand (Neurotrophine-3) and its dependence receptor (TrkC) constitutes a novel mechanism for tumor control in pediatric cancers such as neuroblastoma, and may also be important to the inhibition of other cancers such as breast cancer...

• Perceived Health Can Predict Survival Of Esophago-gastric Cancer

  Posted: March 10th, 2010, 3:00am CST

  Changes in patients' self-rated quality of life after treatment for esophago-gastric cancer can predict the chances for long-term survival. This is the result researchers at the Swedish medical university Karolinska Institutet made, in a new study published in the Journal of Clinical Oncology. The patient's self-rated quality of life, provide indications of whether he or she will survive...

• Designer Nano Luggage To Carry Drugs To Diseased Cells

  Posted: March 10th, 2010, 3:00am CST

  For the first time, scientists have succeeded in growing empty particles derived from a plant virus and have made them carry useful chemicals. The external surface of these nano containers could be decorated with molecules that guide them to where they are needed in the body, before the chemical load is discharged to exert its effect on diseased cells...

• mtm Laboratories Announces The European Launch Of CINtec(R) PLUS

  Posted: March 10th, 2010, 2:00am CST

  mtm laboratories, a privately held diagnostics company announced the launch of CINtec® PLUS, the company's next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer...

• Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin(R)

  Posted: March 10th, 2010, 1:00am CST

  Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin®...

• Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis™ Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium

  Posted: March 10th, 2010, 12:00am CST

  Argos Therapeutics announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium...

• Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU

  Posted: March 9th, 2010, 7:00pm CST

  Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC)...

• ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP

  Posted: March 9th, 2010, 6:00pm CST

  ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC)...

• New Method To Grow Arteries Could Lead To 'Biological Bypass' For Heart Disease

  Posted: March 9th, 2010, 7:00am CST

  A new method of growing arteries could lead to a "biological bypass" - or a non-invasive way to treat coronary artery disease, Yale School of Medicine researchers report with their colleagues in the April issue of Journal of Clinical Investigation. Coronary arteries can become blocked with plaque, leading to a decrease in the supply of blood and oxygen to the heart...

• The Potential For Using Algae To Produce Human Therapeutic Proteins

  Posted: March 9th, 2010, 7:00am CST

  Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae - rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels...

• New Research Shows Immune Cells Use Bungee Of Death To Kill Dangerous Cells

  Posted: March 9th, 2010, 6:00am CST

  Immune cells ensnare dangerous cells that are on the run with a bungee-like nanotube, according to research published in the Proceedings of the National Academy of Sciences. The study, by researchers from Imperial College London, shows that natural killer (NK) cells use this bungee to destroy cells that could otherwise escape them...

• ESMO Conference On Sarcoma And GIST: Spotlight On Rare Tumors In Hunt For New Cancer Treatments

  Posted: March 9th, 2010, 6:00am CST

  New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors...

• News From The Journal Of Clinical Investigation: March 8, 2010

  Posted: March 9th, 2010, 5:00am CST

  Warning sign for potential anticancer approach One treatment being investigated as an adjuvant for anticancer immunotherapies is the use of molecules that trigger the proteins TLR7 and TLR8. For example, the TLR7 stimulant imiquimod is used for the treatment of skin cancer and metastatic melanoma...

• Like Little Golden Assassins, 'Smart' Nanoparticles Identify, Target And Kill Cancer Cells

  Posted: March 9th, 2010, 4:00am CST

  Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone. Led by Carl Batt, the Liberty Hyde Bailey Professor of Food Science, the researchers synthesized nanoparticles shaped something like a dumbbell made of gold sandwiched between two pieces of iron oxide...

• Improvements Needed In Genomic Test Result Discussions

  Posted: March 9th, 2010, 3:00am CST

  One in three early stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of the disease recurring, a new study has found...

• Varian Medical Systems Names Dr. John Adler As Chief Of New Clinical Applications

  Posted: March 9th, 2010, 2:00am CST

  Varian Medical Systems (NYSE: VAR) announced that it has appointed John R. Adler, Jr., M.D., as Vice President and Chief of New Clinical Applications for the company. Dr. Adler, a renowned neurosurgeon, professor of Neurosurgery and Radiation Oncology at Stanford University, and past CEO, chairman and founder of Accuray, Inc...

• Life Technologies, TGen And US Oncology Partner On Groundbreaking Breast Cancer Sequencing Research

  Posted: March 8th, 2010, 7:00am CST

  Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies...

• Occupational Sunlight Exposure And Kidney Cancer Risk In Men

  Posted: March 8th, 2010, 6:00am CST

  According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women...

• Integrated Single Specialty Provider Healthcare Model Can Help Medicare Plans Save Millions By Delivering Evidence-Based Cancer Care

  Posted: March 8th, 2010, 6:00am CST

  New Century Infusion Solutions, Inc. (NCIS), the first Oncology Benefit Management (OBM) company, is pleased to announce the publication of a white paper by the Lewin Group: "Medicare Cancer Care Coordination Using The Integrated Single Specialty Provider (ISSP) Model." The report estimates that over a 10-year horizon, a payer could realize oncology savings of "$16...

• New Sensor Array Detects Single Molecules For The First Time

  Posted: March 8th, 2010, 5:00am CST

  MIT chemical engineers have built a sensor array that, for the first time, can detect single molecules of hydrogen peroxide emanating from a single living cell...

• Research Roundup: Childhood Obesity, Insurance Coverage In Cancer Trials, Hospitals Stays And Need For Nursing Homes

  Posted: March 8th, 2010, 4:00am CST

  Health Affairs this month is devoted to the topic of childhood obesity, with the first study of the group - National, State, And Local Disparities In Childhood Obesity - pointing out that "new data from the 2007 National Survey of Children's Health show that the percentage of children ages 10-17 who are overweight ...

• Post-Op Liver Cancer Complications More Frequent At Low-Volume Hospitals

  Posted: March 7th, 2010, 3:00am CST

  The frequency of post-operative complications following surgery for liver cancer is associated with a hospital having a low volume of liver surgery. Investigators at The Cancer Institute of New Jersey (CINJ) are presenting that finding at the 63rd Annual Society of Surgical Oncology Symposium taking place this week in St. Louis...

• Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium

  Posted: March 7th, 2010, 2:00am CST

  Predictive Biosciences announced that the Company will be presenting its novel Multi-Analyte Diagnostic Readout (MADR™) approach to the development of a non-invasive, urinary biomarker based assay for the detection of bladder cancer during the 2010 Genitourinary Cancers Symposium (GU Symposium), being held March 5-7 in San Francisco...

• NIH Student Award Winner Exploring How Couples Cope With Breast Cancer

  Posted: March 7th, 2010, 2:00am CST

  Amber J. Belcher, a doctoral student in psychology at the University of Delaware, has won the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (NIH). The fellowship will support Belcher's research on how couples cope with breast cancer. Breast cancer is second only to skin cancer as the most common cancer among women in the United States...